3-14819693-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_152536.4(FGD5):c.622G>A(p.Asp208Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000637 in 1,538,858 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152536.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FGD5 | NM_152536.4 | c.622G>A | p.Asp208Asn | missense_variant | 1/20 | ENST00000285046.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FGD5 | ENST00000285046.10 | c.622G>A | p.Asp208Asn | missense_variant | 1/20 | 1 | NM_152536.4 | P1 | |
FGD5 | ENST00000543601.5 | c.-102G>A | 5_prime_UTR_variant | 1/19 | 1 | ||||
FGD5 | ENST00000640506.1 | c.751G>A | p.Asp251Asn | missense_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000351 AC: 5AN: 142270Hom.: 0 AF XY: 0.0000402 AC XY: 3AN XY: 74556
GnomAD4 exome AF: 0.0000656 AC: 91AN: 1386634Hom.: 0 Cov.: 30 AF XY: 0.0000513 AC XY: 35AN XY: 682254
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74420
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.622G>A (p.D208N) alteration is located in exon 1 (coding exon 1) of the FGD5 gene. This alteration results from a G to A substitution at nucleotide position 622, causing the aspartic acid (D) at amino acid position 208 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at